Your browser doesn't support javascript.
loading
Corrigendum to "Interleukin-1ß, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson's disease" [Cell. Immunol. 327 (2018) 77-82].
Karpenko, M N; Vasilishina, A A; Gromova, E A; Muruzheva, Z M; Bernadotte, A.
Affiliation
  • Karpenko MN; Institute of Experimental Medicine, Saint Petersburg, Russian Federation; Peter the Great St Petersburg Polytechnic University, Saint Petersburg, Russian Federation; ITMO University, Saint Petersburg, Russian Federation.
  • Vasilishina AA; Institute of Cytology, Russian Academy of Sciences, Saint Petersburg, Russian Federation.
  • Gromova EA; Institute of Human Brain, Russian Academy of Sciences, Saint Petersburg, Russian Federation.
  • Muruzheva ZM; Institute of Experimental Medicine, Saint Petersburg, Russian Federation.
  • Bernadotte A; Karolinska Institute, Department of Medical Biochemistry & Biophysics, Stockholm, Sweden; Faculty of Mechanics and Mathematics, Lomonosov Moscow State University, Moscow, Russian Federation. Electronic address: alexandra.beradotte@gmail.com.
Cell Immunol ; 334: 99, 2018 12.
Article in En | MEDLINE | ID: mdl-30213645
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Immunol Year: 2018 Document type: Article Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Immunol Year: 2018 Document type: Article Country of publication: Países Bajos